CAR-T Cellular Immunotherapy market

CAR-T Cellular Immunotherapy Market, Global Outlook and Forecast 2022-2028

  • 25 April 2022
  • Life Sciences
  • 66 Pages
  • Report code : PMR-7018807

  • 4.7 (158)

CAR-T Cellular Immunotherapy Market

Download FREE Report Sample

  Download Free sample

A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient?s blood. Then the gene for a special receptor that binds to a certain protein on the patient?s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.

CAR-T Cellular Immunotherapy Market contains market size and forecasts of CAR-T Cellular Immunotherapy in Global, including the following market information:

Global CAR-T Cellular Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CAR-T Cellular Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Allogeneic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CAR-T Cellular Immunotherapy include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR-T Cellular Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CAR-T Cellular Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CAR-T Cellular Immunotherapy Market Segment Percentages, by Type, 2021 (%)

Allogeneic

Autologous

Global CAR-T Cellular Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CAR-T Cellular Immunotherapy Market Segment Percentages, by Application, 2021 (%)

Hospital

Pharmacy

Other

Global CAR-T Cellular Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CAR-T Cellular Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CAR-T Cellular Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CAR-T Cellular Immunotherapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Fosun Kite Biotechnology

Gilead Sciences

Novartis

Bristol-Myers Squibb

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About CAR-T Cellular Immunotherapy Market

Leave This Empty: